356 related articles for article (PubMed ID: 23418360)
1. MicroRNA miR-24 enhances tumor invasion and metastasis by targeting PTPN9 and PTPRF to promote EGF signaling.
Du WW; Fang L; Li M; Yang X; Liang Y; Peng C; Qian W; O'Malley YQ; Askeland RW; Sugg SL; Qian J; Lin J; Jiang Z; Yee AJ; Sefton M; Deng Z; Shan SW; Wang CH; Yang BB
J Cell Sci; 2013 Mar; 126(Pt 6):1440-53. PubMed ID: 23418360
[TBL] [Abstract][Full Text] [Related]
2. miR-96 promotes cell proliferation, migration and invasion by targeting PTPN9 in breast cancer.
Hong Y; Liang H; Uzair-Ur-Rehman ; Wang Y; Zhang W; Zhou Y; Chen S; Yu M; Cui S; Liu M; Wang N; Ye C; Zhao C; Liu Y; Fan Q; Zhang CY; Sang J; Zen K; Chen X
Sci Rep; 2016 Nov; 6():37421. PubMed ID: 27857177
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-34 suppresses breast cancer invasion and metastasis by directly targeting Fra-1.
Yang S; Li Y; Gao J; Zhang T; Li S; Luo A; Chen H; Ding F; Wang X; Liu Z
Oncogene; 2013 Sep; 32(36):4294-303. PubMed ID: 23001043
[TBL] [Abstract][Full Text] [Related]
4. Upregulated microRNA-301a in breast cancer promotes tumor metastasis by targeting PTEN and activating Wnt/β-catenin signaling.
Ma F; Zhang J; Zhong L; Wang L; Liu Y; Wang Y; Peng L; Guo B
Gene; 2014 Feb; 535(2):191-7. PubMed ID: 24315818
[TBL] [Abstract][Full Text] [Related]
5. The miR-200 family regulates the epithelial-mesenchymal transition induced by EGF/EGFR in anaplastic thyroid cancer cells.
Zhang Z; Liu ZB; Ren WM; Ye XG; Zhang YY
Int J Mol Med; 2012 Oct; 30(4):856-62. PubMed ID: 22797360
[TBL] [Abstract][Full Text] [Related]
6. microRNA-133a regulates the cell cycle and proliferation of breast cancer cells by targeting epidermal growth factor receptor through the EGFR/Akt signaling pathway.
Cui W; Zhang S; Shan C; Zhou L; Zhou Z
FEBS J; 2013 Aug; 280(16):3962-74. PubMed ID: 23786162
[TBL] [Abstract][Full Text] [Related]
7. miRNA-491-5p and GIT1 serve as modulators and biomarkers for oral squamous cell carcinoma invasion and metastasis.
Huang WC; Chan SH; Jang TH; Chang JW; Ko YC; Yen TC; Chiang SL; Chiang WF; Shieh TY; Liao CT; Juang JL; Wang HC; Cheng AJ; Lu YC; Wang LH
Cancer Res; 2014 Feb; 74(3):751-64. PubMed ID: 24335959
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-7 functions as an anti-metastatic microRNA in gastric cancer by targeting insulin-like growth factor-1 receptor.
Zhao X; Dou W; He L; Liang S; Tie J; Liu C; Li T; Lu Y; Mo P; Shi Y; Wu K; Nie Y; Fan D
Oncogene; 2013 Mar; 32(11):1363-72. PubMed ID: 22614005
[TBL] [Abstract][Full Text] [Related]
9. miR-7 inhibits the invasion and metastasis of gastric cancer cells by suppressing epidermal growth factor receptor expression.
Xie J; Chen M; Zhou J; Mo MS; Zhu LH; Liu YP; Gui QJ; Zhang L; Li GQ
Oncol Rep; 2014 Apr; 31(4):1715-22. PubMed ID: 24573489
[TBL] [Abstract][Full Text] [Related]
10. Suppression of MIM by microRNA-182 activates RhoA and promotes breast cancer metastasis.
Lei R; Tang J; Zhuang X; Deng R; Li G; Yu J; Liang Y; Xiao J; Wang HY; Yang Q; Hu G
Oncogene; 2014 Mar; 33(10):1287-96. PubMed ID: 23474751
[TBL] [Abstract][Full Text] [Related]
11. Identification of microRNA-214 as a negative regulator of colorectal cancer liver metastasis by way of regulation of fibroblast growth factor receptor 1 expression.
Chen DL; Wang ZQ; Zeng ZL; Wu WJ; Zhang DS; Luo HY; Wang F; Qiu MZ; Wang DS; Ren C; Wang FH; Chiao LJ; Pelicano H; Huang P; Li YH; Xu RH
Hepatology; 2014 Aug; 60(2):598-609. PubMed ID: 24616020
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-218 inhibits cell migration and invasion in renal cell carcinoma through targeting caveolin-2 involved in focal adhesion pathway.
Yamasaki T; Seki N; Yoshino H; Itesako T; Hidaka H; Yamada Y; Tatarano S; Yonezawa T; Kinoshita T; Nakagawa M; Enokida H
J Urol; 2013 Sep; 190(3):1059-68. PubMed ID: 23454155
[TBL] [Abstract][Full Text] [Related]
13. Connective tissue growth factor modulates oral squamous cell carcinoma invasion by activating a miR-504/FOXP1 signalling.
Yang MH; Lin BR; Chang CH; Chen ST; Lin SK; Kuo MY; Jeng YM; Kuo ML; Chang CC
Oncogene; 2012 May; 31(19):2401-11. PubMed ID: 21927029
[TBL] [Abstract][Full Text] [Related]
14. A regulatory loop involving miR-22, Sp1, and c-Myc modulates CD147 expression in breast cancer invasion and metastasis.
Kong LM; Liao CG; Zhang Y; Xu J; Li Y; Huang W; Zhang Y; Bian H; Chen ZN
Cancer Res; 2014 Jul; 74(14):3764-78. PubMed ID: 24906624
[TBL] [Abstract][Full Text] [Related]
15. Downregulation of miR-193b contributes to enhance urokinase-type plasminogen activator (uPA) expression and tumor progression and invasion in human breast cancer.
Li XF; Yan PJ; Shao ZM
Oncogene; 2009 Nov; 28(44):3937-48. PubMed ID: 19701247
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-21 induces breast cancer cell invasion and migration by suppressing smad7 via EGF and TGF-β pathways.
Han M; Wang F; Gu Y; Pei X; Guo G; Yu C; Li L; Zhu M; Xiong Y; Wang Y
Oncol Rep; 2016 Jan; 35(1):73-80. PubMed ID: 26531758
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-133b inhibits the growth of non-small-cell lung cancer by targeting the epidermal growth factor receptor.
Liu L; Shao X; Gao W; Zhang Z; Liu P; Wang R; Huang P; Yin Y; Shu Y
FEBS J; 2012 Oct; 279(20):3800-12. PubMed ID: 22883469
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-137, an HMGA1 target, suppresses colorectal cancer cell invasion and metastasis in mice by directly targeting FMNL2.
Liang L; Li X; Zhang X; Lv Z; He G; Zhao W; Ren X; Li Y; Bian X; Liao W; Liu W; Yang G; Ding Y
Gastroenterology; 2013 Mar; 144(3):624-635.e4. PubMed ID: 23201162
[TBL] [Abstract][Full Text] [Related]
19. miR-340 inhibition of breast cancer cell migration and invasion through targeting of oncoprotein c-Met.
Wu ZS; Wu Q; Wang CQ; Wang XN; Huang J; Zhao JJ; Mao SS; Zhang GH; Xu XC; Zhang N
Cancer; 2011 Jul; 117(13):2842-52. PubMed ID: 21692045
[TBL] [Abstract][Full Text] [Related]
20. DU145 human prostate carcinoma invasiveness is modulated by urokinase receptor (uPAR) downstream of epidermal growth factor receptor (EGFR) signaling.
Mamoune A; Kassis J; Kharait S; Kloeker S; Manos E; Jones DA; Wells A
Exp Cell Res; 2004 Sep; 299(1):91-100. PubMed ID: 15302576
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
